Public Health Emergency - Leading a Nation Prepared
The majority of stockpile assets are held in storage and kept as managed inventory. Maintaining a supply of medications and medical supplies for specific health threats allows the stockpile to respond with the right product when a specific disease or agent is known.
Products in the stockpile may require an
Emergency Use Authorization, which is granted by the U.S. Food and Drug Administration (FDA). The authorization allows for the emergency use of an unapproved medical product (e.g., drugs, vaccines, and devices) or unapproved use of an approved medical product to diagnose, treat, or prevent serious or life-threatening diseases or conditions for which no adequate, FDA-approved alternative is available.
If a community experiences a large-scale public health incident in which the disease or agent is unknown, the first line of support from the stockpile is to send a broad-range of pharmaceuticals and medical supplies. Contents are pre-packed and configured in transport-ready containers for rapid delivery anywhere in the United States within 12 hours of the federal decision to deploy. Each package contains 50 tons of emergency medical resources.
The stockpile has medicines and supplies stored in strategically located warehouses throughout the country ready for deployment. Immediately shipping a variety of items to the affected state allows authorities to begin or sustain response efforts. All states have plans to receive and distribute these medical countermeasures quickly to local jurisdictions.
For further questions or information about the Strategic National Stockpile (SNS), please email us at email@example.com
Home | Contact Us | Accessibility | Privacy Policies | Disclaimer | HHS Viewers & Players | HHS Plain Language
Assistant Secretary for Preparedness and Response (ASPR), 200 Independence Ave., SW, Washington, DC 20201
U.S. Department of Health and Human Services | USA.gov |
HealthCare.gov in Other Languages